Columbus, OH, United States of America

Michael A Caligiuri

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Michael A. Caligiuri: Innovator in Cancer Treatment and Immunology

Introduction

Michael A. Caligiuri is a prominent inventor based in Columbus, OH (US), known for his significant contributions to the fields of immunology and cancer treatment. With a total of 10 patents, Caligiuri has developed innovative methods that enhance therapeutic approaches for various diseases, particularly those related to cancer.

Latest Patents

Among his latest patents, Caligiuri has introduced groundbreaking methods for treating subjects infected with pathogens. One notable patent describes a method of administering a pharmaceutical composition comprising an Fc region of an immunoglobulin G antibody to effectively treat infections. Additionally, he has developed methods for treating cancer in subjects undergoing oncolytic viral therapy, which also utilize the Fc region of immunoglobulin G antibodies to activate natural killer (NK) cells. Another significant patent focuses on EGFR-directed CAR therapy for glioblastoma, addressing the aggressive nature of this brain malignancy and exploring the use of CAR-modified immune cells in treating brain cancers.

Career Highlights

Caligiuri has worked with esteemed organizations such as the Ohio State Innovation Foundation and Health Research, Inc. His work has been pivotal in advancing cancer therapies and enhancing the understanding of immune responses to various pathogens.

Collaborations

Throughout his career, Caligiuri has collaborated with notable colleagues, including Jianhua Yu and Neal J. Meropol, contributing to the development of innovative therapeutic strategies.

Conclusion

Michael A. Caligiuri's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer and infectious diseases. His patents reflect a commitment to improving patient outcomes through advanced therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…